NTHI
NeOnc Technologies Holdings, Inc. Common Stock
NASDAQ: NTHI · HEALTHCARE · BIOTECHNOLOGY
$5.45
-16.02% today
Updated 2026-05-08
Market cap
$137.81M
P/E ratio
—
P/S ratio
3,446.01x
EPS (TTM)
$-3.20
Dividend yield
—
52W range
$3 – $13
Volume
0.1M
NeOnc Technologies Holdings, Inc. Common Stock (NTHI) Financial statements
SEC filings — annual and quarterly data.
Income statement — annual
| Item | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|
| Revenue | $0.00 | $20000.00 | $70462.00 | $83000.00 | $39990.00 |
| Revenue growth (YoY) | — | — | +252.3% | +17.8% | -51.8% |
| Cost of revenue | — | — | $2.74M | — | — |
| Gross profit | — | $20000.00 | $70462.00 | $83000.00 | $39990.00 |
| Gross margin | — | 100.0% | 100.0% | 100.0% | 100.0% |
| R&D | $674558.00 | $1.16M | $1.53M | $3.05M | $3.64M |
| SG&A | $2.60M | $1.69M | $3.40M | $3.64M | $42.85M |
| Operating income | $-3.27M | $-2.84M | $-12.20M | $-7.14M | $-58.17M |
| Operating margin | — | -14188.0% | -17311.0% | -8605.4% | -145459.4% |
| EBITDA | $-3.26M | $-2.85M | $-12.20M | $-9.10M | $-59.61M |
| EBITDA margin | — | -14233.0% | -17311.0% | -10958.4% | -149050.2% |
| EBIT | $-3.27M | $-2.84M | $-12.20M | $-9.34M | $-59.64M |
| Interest expense | $112919.00 | $200153.00 | $2.72M | $2.70M | $2.50M |
| Income tax | — | — | — | — | — |
| Effective tax rate | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% |
| Net income | $-3.38M | $-3.05M | $-14.92M | $-11.90M | $-62.15M |
| Net income growth (YoY) | — | +9.7% | -389.7% | +20.3% | -422.3% |
| Profit margin | — | -15233.8% | -21176.0% | -14335.5% | -155404.4% |